<DOC>
	<DOCNO>NCT01717040</DOCNO>
	<brief_summary>The primary objective test hypothesis adjunctive pioglitazone effective placebo relief acute depressive symptom result bipolar disorder . The secondary objective determine potential moderator mediator antidepressant efficacy .</brief_summary>
	<brief_title>Pioglitazone Treatment Bipolar Depression</brief_title>
	<detailed_description>The study double-blind , placebo-controlled 8-week trial pioglitazone , either monotherapy adjunctive mood stabilizer , acute relief bipolar depression . The enrollment goal 80 subject ( 40 patient pioglitazone treatment group placebo treatment group ) . Screening Phase : Patients prescribe mood stabilizer &gt; 4 week therapeutic dose proceed directly Screening Visit . For situation patient prefers take mood stabilizer treat psychiatrist feel clinically necessary , mood stabilizer ( lithium , divalproex , carbamazepine , lamotrigine , olanzapine , quetiapine , risperidone , aripiprazole , ziprasidone lurasidone ) initiate ( see Mood Stabilizer Initiation section ) . For set patient begin mood stabilizer , Screening Phase may last 8 week . Otherwise , subject come mood stabilizer proceed directly screen . Double-Blind , Placebo-Controlled Study Period ( Week 1 Week 8 ) : Patients meet inclusion/exclusion criterion randomize study treatment baseline/randomization visit within 30 day screen visit . The efficacy safety assessment carry baseline/randomization weekly every two week total 8 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Be male female &gt; = 18 year age Diagnostic Statistical ManualIV ( DSMIV ) diagnosis bipolar disorder ( type I , II , NOS ) Currently depress confirm MiniInternational Neuropsychiatric Interview ( M.I.N.I . ) Plus screen visit Inventory Depressive Symptoms total score &gt; 25 Quick Inventory Depressive SymptomatologySelfReport ( QIDSSR16 ) &gt; 11 study baseline Women childbearing potential ( surgically sterile 2 year postmenopausal ) , must use medically accept method contraception must agree continue use method duration study 30 day participation study . Acceptable method contraception include barrier method spermicide , abstinence , intrauterine device ( IUD ) , steroidal contraceptive ( oral , transdermal , implanted , inject ) conjunction barrier method . Pregnant breast feed Unstable inadequately treat medical illness judge investigator Severe personality disorder Serious suicidal risk judge investigator score â‰¥ 4 Montgomery Asberg Depression Rating Scale ( MADRS ) item number 10 ( suicidal thought ) screen baseline Known history intolerance hypersensitivity pioglitazone Treatment pioglitazone 3 month prior randomization Dependence alcohol drug ( nicotine ) 3 month prior study entry Currently take insulin rosiglitazone . Diagnosed dementia Acute Mania define Young Mania Rating Scale ( YMRS ) score &gt; 15 Diagnosed heart failure Transaminase elevation &gt; 2.5 time upper limit normal Presence renal impairment ( eg . creatinine &gt; 1.5 ) History bladder carcinoma Fasting blood glucose &gt; 150 mg/dL Hb A1c &gt; 7 % ; participant meet criterion refer endocrinologist primary care physician diabetes evaluation education . Receiving acute series electroconvulsive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Insulin Resistance</keyword>
</DOC>